Correlation Between Cingulate Warrants and Entero Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate Warrants and Entero Therapeutics,, you can compare the effects of market volatilities on Cingulate Warrants and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Entero Therapeutics,.

Diversification Opportunities for Cingulate Warrants and Entero Therapeutics,

-0.47

Correlation Coefficient

Cingulate Warrants  Entero Therapeutics,

Very good diversification

The 3 months correlation between Cingulate and Entero is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Entero Therapeutics,

Assuming the 90 days horizon Cingulate Warrants is expected to generate 1.36 times more return on investment than Entero Therapeutics,. However, Cingulate Warrants is 1.36 times more volatile than Entero Therapeutics,. It trades about 0.06 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about 0.07 per unit of risk. If you would invest  5.77  in Cingulate Warrants on September 5, 2024 and sell it today you would lose (0.92) from holding Cingulate Warrants or give up 15.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Cingulate Warrants  vs.  Entero Therapeutics,

Cingulate Warrants

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate Warrants are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

Entero Therapeutics,

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cingulate Warrants and Entero Therapeutics,

The main advantage of trading using opposite Cingulate Warrants and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.

The idea behind Cingulate Warrants and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.